BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -450.10K | -1.14M | -1.51M | -1.58M | -3.49M |
| Total Depreciation and Amortization | 337.20K | 745.50K | 762.80K | 784.20K | 755.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 40.20K |
| Total Other Non-Cash Items | 222.30K | 189.50K | 55.30K | 28.70K | 41.60K |
| Change in Net Operating Assets | -485.30K | 69.80K | 177.60K | 1.27M | 3.66M |
| Cash from Operations | -375.90K | -138.90K | -517.00K | 505.40K | 1.01M |
| Capital Expenditure | -53.00K | -44.90K | -12.90K | -14.50K | 10.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -1.00K | -1.00K | -1.00K | -1.00K |
| Cash from Investing | -53.00K | -45.80K | -13.80K | -15.40K | 9.20K |
| Total Debt Issued | 1.13M | 1.47M | 1.49M | 1.49M | 525.00K |
| Total Debt Repaid | -392.20K | -386.40K | -355.30K | -388.00K | -413.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -889.00K | -763.60K | -695.60K | -660.20K | -294.70K |
| Cash from Financing | -109.50K | 236.30K | 326.30K | 329.00K | -133.50K |
| Foreign Exchange rate Adjustments | 532.10K | -135.50K | 114.30K | 40.10K | -841.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.30K | -84.00K | -90.20K | 859.00K | 39.70K |
